Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5984574 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL736070 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL5985367 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL2367356 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL5985370 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL294865 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL5984140 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL5986484 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL5986344 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 | |
| SCHEMBL739205 | 1.00 | TRPV1 (0.31) | TRPV1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024116991-A1 | WEAR INHIBITOR AND LUBRICATING OIL COMPOSITION | 三洋化成工業株式会社 | 2024-06-06 | — | — | WO | disclosed |
| WO-2024116990-A1 | FRICTION MODIFIER AND LUBRICANT COMPOSITION | 三洋化成工業株式会社 | 2024-06-06 | — | — | WO | disclosed |
| CN-117062875-A | Polycarbonate resin composition | 三菱工程塑料株式会社 | 2023-11-14 | — | — | CN | disclosed |
| US-11377455-B2 | Preparation of organosilicon compound having (meth)acryloyloxy group | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-07-05 | — | — | US | disclosed |
| US-20220064372-A1 | POLYCARBONATE POLYOL AND USES OF THE SAME | DAIREN CHEMICAL CORPORATION (TW) | 2022-03-03 | — | — | US | disclosed |
| CN-114106314-A | Polycarbonate polyols and use thereof | 大连化学工业股份有限公司 | 2022-03-01 | — | — | CN | disclosed |
| EP-3904422-A1 | URETHANE POLYMER AND OIL COMPOSITION CONTAINING SAME | ADEKA CORPORATION (JP) | 2021-11-03 | — | — | EP | disclosed |
| US-20210139515-A1 | Preparation of Organosilicon Compound Having (Meth)acryloyloxy Group | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-05-13 | — | — | US | disclosed |
| EP-3819301-A1 | PREPARATION OF ORGANOSILICON COMPOUND HAVING (METH)ACRYLOYLOXY GROUP | Shin-Etsu Chemical Co., Ltd. (JP) | 2021-05-12 | — | — | EP | disclosed |
| CN-110791964-B | Treating agent for elastic fiber and elastic fiber | 竹本油脂株式会社 | 2020-10-23 | — | — | CN | disclosed |
| WO-2020162248-A1 | URETHANE-MODIFIED SILICONE, AND OIL COMPOSITION AND COSMETIC COMPOSITION CONTAINING SAME | 株式会社ADEKA | 2020-08-13 | — | — | WO | disclosed |
| WO-2020137679-A1 | URETHANE POLYMER AND OIL COMPOSITION CONTAINING SAME | 株式会社ADEKA | 2020-07-02 | — | — | WO | disclosed |
| CN-110791964-A | Treating agent for elastic fiber and elastic fiber | 竹本油脂株式会社 | 2020-02-14 | — | — | CN | disclosed |
| EP-2367056-A2 | Method of preparing lithographic printing plate | Fujifilm Corporation (JP) | 2011-09-21 | — | — | EP | disclosed |
| US-7018993-B2 | Antiandrogenic agent | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2006-03-28 | — | — | US | disclosed |
| US-20030158164-A1 | Novel antiandrogenic agent | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-08-21 | — | — | US | disclosed |
| EP-1304334-A1 | NOVEL ANTIANDROGENIC AGENT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-04-23 | — | — | EP | disclosed |
| EP-1219631-A1 | ANTIANDROGEN AGENTS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-07-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11377455-B2 | Preparation of organosilicon compound having (meth)acryloyloxy group | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, MMAB, ACR | TRPV1 4173/4885TRPA1 1130/4885 |
| US-20210139515-A1 | Preparation of Organosilicon Compound Having (Meth)acryloyloxy Group | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, MMAB, ACR | TRPV1 4211/4885TRPA1 1204/4885 |
| US-20030158164-A1 | Novel antiandrogenic agent | NR5A1, CYP19A1, HSD17B11 | TRPV1 4436/4885TRPA1 4527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.